[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Amgen, Inc. (AMGN) FDA approves Tezspire for chronic rhinosinusitis with nasal polyps, a major win for Amgen and AstraZeneca. Amgen's stock is trending positively with increased social dominance and market cap gains. ### About Amgen, Inc. Amgen, Inc. (AMGN) is a biotechnology company focused on developing and delivering innovative human therapeutics. Amgen, Inc. uses the ticker $AMGN for trading. Listed in the [Stocks](/list/stocks) and category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights [#](/topic/$amgn/insights) - Amgen, Inc. (AMGN) social dominance is up XXXXXX% from the previous week. - Amgen, Inc. (AMGN) galaxy score™ is up XXXXX% from the previous week. ### Price: $XXXXXX [#](/topic/$amgn/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/close.tsv) The price is currently at $277.50, with a XXXX% increase in the last XX hours, and positive sentiment and news about Amgen's advancements, along with the market cap, suggest a bullish trend. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | XXXX% | XXXX% | XXX% | **1-Year High**: $XXXXXX on 2025-03-10 **1-Year Low**: $XXXXXX on 2025-01-06 ### AltRank: XXXXX [#](/topic/$amgn/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/alt_rank.tsv) Amgen, Inc. (AMGN) is currently AltRank #1,164 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXX -XXX **1 Month**: XXXXX +1,099 **6 Months**: XXXXX +251 **1 Year**: XXXXX +1,117 **1-Year High**: XXXXX on 2024-11-02 **1-Year Low**: XX on 2024-12-29 ### Galaxy Score: XXXXX [#](/topic/$amgn/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX +21 **1 Month**: XX -XX **6 Months**: XX -XX **1 Year**: XX -XX **1-Year High**: XX on 2025-05-27 **1-Year Low**: X on 2024-11-11 ### Engagements: XXXXXX [#](/topic/$amgn/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/interactions.tsv) **Current Value**: XXXXXX **Daily Average**: XXXXXXX **1 Week**: XXXXXXX -XX% **1 Month**: XXXXXXXXX -XX% **6 Months**: XXXXXXXXXX +4.40% **1 Year**: XXXXXXXXXX -XX% **1-Year High**: XXXXXXXXX on 2025-02-04 **1-Year Low**: XXXXX on 2025-10-20 | Social Network | X | TikTok | YouTube | Reddit | News | | -------------- | - | ------ | ------- | ------ | ---- | | Engagements | XXXXXX | XXXXX | XXXXX | XX | XXX | ### Mentions: XXX [#](/topic/$amgn/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/posts_active.tsv) **Current Value**: XXX **Daily Average**: XXX **1 Week**: XXX -XX% **1 Month**: XXXXX -XX% **6 Months**: XXXXXX +12% **1 Year**: XXXXXX +1.20% **1-Year High**: XXXXX on 2024-11-28 **1-Year Low**: XXX on 2025-01-27 | Social Network | X | TikTok | YouTube | Reddit | News | | -------------- | - | ------ | ------- | ------ | ---- | | Mentions | XXX | XX | XXX | X | X | ### Creators: XXX [#](/topic/$amgn/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/contributors_active.tsv) XXX unique social accounts have posts mentioning Amgen, Inc. (AMGN) in the last XX hours which is up X% from XXX in the previous XX hours **Daily Average**: XXX **1 Week**: XXX -XX% **1 Month**: XXXXX -XX% **6 Months**: XXXXX +56% **1 Year**: XXXXXX +103% **1-Year High**: XXX on 2025-09-04 **1-Year Low**: XX on 2025-01-26 The most influential creators that mention Amgen, Inc. in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@bioinvestor24](/creator/twitter/bioinvestor24) | X | XXXXX | X | XXXXX | | [@dpworldtour](/creator/youtube/dpworldtour) | X | XXXXXXX | X | XXXXX | | [@amgen](/creator/youtube/amgen) | X | XXXXXX | XX | XXXXX | | [@A1PHAEDGE](/creator/twitter/A1PHAEDGE) | X | XXX | XX | XXX | | [@Biobeats99](/creator/twitter/Biobeats99) | X | XXX | X | XXX | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XXX | | [@arpita37898816](/creator/twitter/arpita37898816) | X | XXX | XX | XXX | | [@nucleusmedicalmedia](/creator/youtube/nucleusmedicalmedia) | X | XXXXXXXXX | X | XXX | | [@Darwin_Knows](/creator/twitter/Darwin_Knows) | X | XXX | X | XXX | | [@amgenbiotech](/creator/tiktok/amgenbiotech) | XX | XXXXX | XX | XXX | [View More](/list/creators/$amgn/100) ### Sentiment: XX% [#](/topic/$amgn/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% +3% **1 Month**: XX% no change **6 Months**: XX% +6% **1 Year**: XX% no change **1-Year High**: XX% on 2025-09-07 **1-Year Low**: XX% on 2024-11-26 **Most Supportive Themes** - **Positive Sentiment and News Mentions:** (40%) Posts highlighting Amgen's advancements and positive news coverage. - **Product and Partnership Announcements:** (30%) Announcements regarding new products, partnerships, and clinical trial results. - **Industry Recognition and Awards:** (15%) Mentions of Amgen being recognized as a top employer and receiving industry awards. **Most Critical Themes** - **Market and Economic Concerns:** (10%) Posts expressing concerns about market dominance and potential impacts of tariffs and economic factors. - **Competition and Market Dynamics:** (5%) Discussions about competitors and the competitive landscape in the pharmaceutical industry. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXXXX | XX% | XXX | X% | | TikTok | XXX | X% | XXX | X% | X | X% | | YouTube | XXXXX | X% | XXXXX | XX% | XXX | X% | | Reddit | XX | X% | XX | X% | X | X% | | News | XXX | X% | X | X% | X | X% | | | | | | | | | | Total | XXXXX | XX% | XXXXX | XX% | XXX | X% | ### Social Dominance: XXXXX% [#](/topic/$amgn/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/social_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXX% +0.037% **1 Month**: XXXXX% -XXXXX% **6 Months**: XXXXX% -XXXXX% **1 Year**: XXXXX% -XXXXX% **1-Year High**: XXXXX% on 2024-11-27 **1-Year Low**: XXXXX% on 2025-07-29 ### Market Dominance: XXXXX% [#](/topic/$amgn/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/market_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2025-03-12 **1-Year Low**: XXXX% on 2025-09-25 ### Market Cap: $XXXXXXXXXXXXXXX [#](/topic/$amgn/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$amgn/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXXXX +$2.60% **1 Month**: $XXXXXXXXXXXXXXX +$4.70% **6 Months**: $XXXXXXXXXXXXXXX +$7.50% **1 Year**: $XXXXXXXXXXXXXXX -$7% **1-Year High**: $XXXXXXXXXXXXXXX on 2025-03-10 **1-Year Low**: $XXXXXXXXXXXXXXX on 2025-01-06 **Top assets mentioned** In the posts about Amgen, Inc. in the last XX hours [Merck & Co., Inc. (MRK)](/topic/$mrk) [Pfizer, Inc. (PFE)](/topic/$pfe) [AstraZeneca PLC (AZN)](/topic/$azn) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [AbbVie Inc (ABBV)](/topic/$abbv) [QUALCOMM, Inc. (QCOM)](/topic/$qcom) [T-Mobile (TMUS)](/topic/$tmus) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Sanofi (SNY)](/topic/sanofi) **Top topics mentioned** In the posts about Amgen, Inc. in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [stocks technology](/topic/stocks-technology), [$mrk](/topic/$mrk), [$pfe](/topic/$pfe), [stocks industrials](/topic/stocks-industrials), [stocks communication services](/topic/stocks-communication-services), [$azn](/topic/$azn), [eli lilly](/topic/eli-lilly), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks](/topic/stocks), [$abbv](/topic/$abbv), [stocks financial services](/topic/stocks-financial-services), [coins base ecosystem](/topic/coins-base-ecosystem), [$qcom](/topic/$qcom), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$tmus](/topic/$tmus), [$bmy](/topic/$bmy), [sanofi](/topic/sanofi), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$tmo](/topic/$tmo), [investment](/topic/investment), [approved](/topic/approved), [novartis](/topic/novartis), [advanced micro devices](/topic/advanced-micro-devices), [manat](/topic/manat), [rory](/topic/rory), [dp](/topic/dp), [$enb](/topic/$enb), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$husa](/topic/$husa), [tesla](/topic/tesla), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$aapl](/topic/$aapl), [gilead sciences](/topic/gilead-sciences), [$vktx](/topic/$vktx), [exxon mobil](/topic/exxon-mobil), [has been](/topic/has-been), [$novnsw](/topic/$novnsw), [$ecda](/topic/$ecda), [$nvo](/topic/$nvo), [$lly](/topic/$lly), [coins defi](/topic/coins-defi), [$ul](/topic/$ul), [$regn](/topic/$regn), [$nwbo](/topic/$nwbo), [stocks basic materials](/topic/stocks-basic-materials), [fda](/topic/fda), [puerto rico](/topic/puerto-rico), [employees](/topic/employees), [johnson johnson](/topic/johnson-johnson), [stocks energy](/topic/stocks-energy), [money](/topic/money), [donald trump](/topic/donald-trump), [$idya](/topic/$idya), [nasdaq](/topic/nasdaq), [ireland](/topic/ireland), [$gdrx](/topic/$gdrx), [$curr](/topic/$curr), [$ibo](/topic/$ibo), [tariffs](/topic/tariffs), [$nams](/topic/$nams), [$unh](/topic/$unh), [stocks defense](/topic/stocks-defense), [$zlab](/topic/$zlab), [$cmcsa](/topic/$cmcsa), [$nvs](/topic/$nvs), [$pcar](/topic/$pcar), [$dtruy](/topic/$dtruy), [stocks banks](/topic/stocks-banks), [$xbi](/topic/$xbi), [$zeoaf](/topic/$zeoaf), [$bmrn](/topic/$bmrn), [discord](/topic/discord), [coins exchange tokens](/topic/coins-exchange-tokens), [$gild](/topic/$gild), [exit](/topic/exit), [dp world](/topic/dp-world), [$mtsr](/topic/$mtsr), [$team](/topic/$team), [microsoft](/topic/microsoft), [$mlr](/topic/$mlr), [$bbio](/topic/$bbio), [walt disney](/topic/walt-disney), [$indo](/topic/$indo), [$hubc](/topic/$hubc), [$icon](/topic/$icon), [bitmine](/topic/bitmine), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$roiv](/topic/$roiv), [$imvt](/topic/$imvt), [$amd](/topic/$amd), [$smci](/topic/$smci), [$uber](/topic/$uber), [acquisition](/topic/acquisition), [west pharmaceutical services inc](/topic/west-pharmaceutical-services-inc), [$wst](/topic/$wst), [$bjdx](/topic/$bjdx), [$rhhby](/topic/$rhhby), [$xrtx](/topic/$xrtx), [coins dao](/topic/coins-dao) ### Top News [#](/topic/$amgn/news) --- Top news links shared on social in the last XX hours *Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.* "FDA APPROVES TEZSPIRE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS" [News Link](https://www.prnewswire.com/news-releases/fda-approves-tezspire-for-chronic-rhinosinusitis-with-nasal-polyps-302587969.html) [@abcnews](/creator/x/abcnews) 2025-10-17T20:02Z 208.1M followers, 1174 engagements ### Top Social Posts [#](/topic/$amgn/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "🚓💬🏫🧈💤 You can follow him:@gjm6000. I made several times the profit in just a few days by buying the stocks he recommended. He is worth following. #stock $BJDX Nasdaq ➖ $JNJ FundamentalAnalysis🍓 $LMT ChiNext💇 $AMZN InitialPublicOffering📱 $AMGN" [X Link](https://x.com/AshleeBogg16869/status/1980169503582626207) [@AshleeBogg16869](/creator/x/AshleeBogg16869) 2025-10-20T07:09Z X followers, XX engagements "AstraZeneca Tezspire approved in the US for chronic rhinosinusitis with nasal polyps #AZN #RNS #Stocks #AstraZeneca #Oncology #RareDisease #BioPharmaceuticals #Cardiovascular #Respiratory #Immunology #FTSE100 #Investing #Tezspire #Amgen" [X Link](https://x.com/DirectorsTalk/status/1980156504863916147) [@DirectorsTalk](/creator/x/DirectorsTalk) 2025-10-20T06:17Z 51.4K followers, XXX engagements "Breakthrough in Swing Trading: Strategies Backtesting and AI-Powered Robots $LLY $LNJ $MRK $ABBV $AZN $PFE $AMGN $BMY $GILD $BIIB #AITrading" [X Link](https://x.com/Tickeron/status/1980142739468824785) [@Tickeron](/creator/x/Tickeron) 2025-10-20T05:23Z 19.4K followers, XXX engagements "Still like $IDYA as one of best ideas. primarily for DLL3 ADC that showed excellent data competitive with $AMGN bi engager. MAT2A inh is not competitive on efficacy with PRMT5 I from $TNGX or $BMY IDYA has not updated any single agent activity for about X years on very small sample. Doubt $RHHBY will consider it vs PRMT5. Roche chief scientist Garraway discovered SL with MTAP deletion and will likely know how to look at clinical data PKC inh likely to get approval in UM with pos upcoming trial but was expecting more from phase X ( OS XX months in comparison with 18-19 months with ipi nivo" [X Link](https://x.com/bioinvestor24/status/1980103053421564299) [@bioinvestor24](/creator/x/bioinvestor24) 2025-10-20T02:45Z 4395 followers, 1564 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
FDA approves Tezspire for chronic rhinosinusitis with nasal polyps, a major win for Amgen and AstraZeneca. Amgen's stock is trending positively with increased social dominance and market cap gains.
Amgen, Inc. (AMGN) is a biotechnology company focused on developing and delivering innovative human therapeutics.
Amgen, Inc. uses the ticker $AMGN for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The price is currently at $277.50, with a XXXX% increase in the last XX hours, and positive sentiment and news about Amgen's advancements, along with the market cap, suggest a bullish trend.
24-Hour | 7-Day | 30-Day |
---|---|---|
XXXX% | XXXX% | XXX% |
1-Year High: $XXXXXX on 2025-03-10
1-Year Low: $XXXXXX on 2025-01-06
AltRank 24-Hour Time-Series Raw Data
Amgen, Inc. (AMGN) is currently AltRank #1,164 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXXXX +1,099
6 Months: XXXXX +251
1 Year: XXXXX +1,117
1-Year High: XXXXX on 2024-11-02
1-Year Low: XX on 2024-12-29
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +21
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-05-27
1-Year Low: X on 2024-11-11
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXX -XX%
1 Month: XXXXXXXXX -XX%
6 Months: XXXXXXXXXX +4.40%
1 Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-02-04
1-Year Low: XXXXX on 2025-10-20
Social Network | X | TikTok | YouTube | News | |
---|---|---|---|---|---|
Engagements | XXXXXX | XXXXX | XXXXX | XX | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXXX +12%
1 Year: XXXXXX +1.20%
1-Year High: XXXXX on 2024-11-28
1-Year Low: XXX on 2025-01-27
Social Network | X | TikTok | YouTube | News | |
---|---|---|---|---|---|
Mentions | XXX | XX | XXX | X | X |
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Amgen, Inc. (AMGN) in the last XX hours which is up X% from XXX in the previous XX hours
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXX +56%
1 Year: XXXXXX +103%
1-Year High: XXX on 2025-09-04
1-Year Low: XX on 2025-01-26
The most influential creators that mention Amgen, Inc. in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@bioinvestor24 | X | XXXXX | X | XXXXX |
@dpworldtour | X | XXXXXXX | X | XXXXX |
@amgen | X | XXXXXX | XX | XXXXX |
@A1PHAEDGE | X | XXX | XX | XXX |
@Biobeats99 | X | XXX | X | XXX |
@BiopharmIQ | X | XXXXXX | X | XXX |
@arpita37898816 | X | XXX | XX | XXX |
@nucleusmedicalmedia | X | XXXXXXXXX | X | XXX |
@Darwin_Knows | X | XXX | X | XXX |
@amgenbiotech | XX | XXXXX | XX | XXX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +3%
1 Month: XX% no change
6 Months: XX% +6%
1 Year: XX% no change
1-Year High: XX% on 2025-09-07
1-Year Low: XX% on 2024-11-26
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
TikTok | XXX | X% | XXX | X% | X | X% |
YouTube | XXXXX | X% | XXXXX | XX% | XXX | X% |
XX | X% | XX | X% | X | X% | |
News | XXX | X% | X | X% | X | X% |
Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.037%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-11-27
1-Year Low: XXXXX% on 2025-07-29
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-12
1-Year Low: XXXX% on 2025-09-25
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXXX +$2.60%
1 Month: $XXXXXXXXXXXXXXX +$4.70%
6 Months: $XXXXXXXXXXXXXXX +$7.50%
1 Year: $XXXXXXXXXXXXXXX -$7%
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-10
1-Year Low: $XXXXXXXXXXXXXXX on 2025-01-06
Top assets mentioned In the posts about Amgen, Inc. in the last XX hours
Merck & Co., Inc. (MRK) Pfizer, Inc. (PFE) AstraZeneca PLC (AZN) Eli Lilly and Company (LLY) AbbVie Inc (ABBV) QUALCOMM, Inc. (QCOM) T-Mobile (TMUS) Bristol-Myers Squibb Co (BMY) Sanofi (SNY)
Top topics mentioned In the posts about Amgen, Inc. in the last XX hours
stocks healthcare, stocks technology, $mrk, $pfe, stocks industrials, stocks communication services, $azn, eli lilly, stocks consumer cyclical, stocks, $abbv, stocks financial services, coins base ecosystem, $qcom, coins solana ecosystem, $tmus, $bmy, sanofi, stocks consumer defensive, $tmo, investment, approved, novartis, advanced micro devices, manat, rory, dp, $enb, regeneron pharmaceuticals inc, $husa, tesla, stocks bitcoin treasuries, $aapl, gilead sciences, $vktx, exxon mobil, has been, $novnsw, $ecda, $nvo, $lly, coins defi, $ul, $regn, $nwbo, stocks basic materials, fda, puerto rico, employees, johnson johnson, stocks energy, money, donald trump, $idya, nasdaq, ireland, $gdrx, $curr, $ibo, tariffs, $nams, $unh, stocks defense, $zlab, $cmcsa, $nvs, $pcar, $dtruy, stocks banks, $xbi, $zeoaf, $bmrn, discord, coins exchange tokens, $gild, exit, dp world, $mtsr, $team, microsoft, $mlr, $bbio, walt disney, $indo, $hubc, $icon, bitmine, stocks crypto treasuries, $roiv, $imvt, $amd, $smci, $uber, acquisition, west pharmaceutical services inc, $wst, $bjdx, $rhhby, $xrtx, coins dao
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"FDA APPROVES TEZSPIRE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS"
News Link @abcnews 2025-10-17T20:02Z 208.1M followers, 1174 engagements
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🚓💬🏫🧈💤 You can follow him:@gjm6000. I made several times the profit in just a few days by buying the stocks he recommended. He is worth following. #stock $BJDX Nasdaq ➖ $JNJ FundamentalAnalysis🍓 $LMT ChiNext💇 $AMZN InitialPublicOffering📱 $AMGN"
X Link @AshleeBogg16869 2025-10-20T07:09Z X followers, XX engagements
"AstraZeneca Tezspire approved in the US for chronic rhinosinusitis with nasal polyps #AZN #RNS #Stocks #AstraZeneca #Oncology #RareDisease #BioPharmaceuticals #Cardiovascular #Respiratory #Immunology #FTSE100 #Investing #Tezspire #Amgen"
X Link @DirectorsTalk 2025-10-20T06:17Z 51.4K followers, XXX engagements
"Breakthrough in Swing Trading: Strategies Backtesting and AI-Powered Robots $LLY $LNJ $MRK $ABBV $AZN $PFE $AMGN $BMY $GILD $BIIB #AITrading"
X Link @Tickeron 2025-10-20T05:23Z 19.4K followers, XXX engagements
"Still like $IDYA as one of best ideas. primarily for DLL3 ADC that showed excellent data competitive with $AMGN bi engager. MAT2A inh is not competitive on efficacy with PRMT5 I from $TNGX or $BMY IDYA has not updated any single agent activity for about X years on very small sample. Doubt $RHHBY will consider it vs PRMT5. Roche chief scientist Garraway discovered SL with MTAP deletion and will likely know how to look at clinical data PKC inh likely to get approval in UM with pos upcoming trial but was expecting more from phase X ( OS XX months in comparison with 18-19 months with ipi nivo"
X Link @bioinvestor24 2025-10-20T02:45Z 4395 followers, 1564 engagements
/topic/$amgn